Literature DB >> 22238334

Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens.

Jennifer M Mitchell1, James P O'Neil, Mustafa Janabi, Shawn M Marks, William J Jagust, Howard L Fields.   

Abstract

Excessive consumption of alcohol is among the leading causes of preventable death worldwide. Although ethanol modulates a variety of molecular targets, including several neurotransmitter receptors, the neural mechanisms that underlie its rewarding actions and lead to excessive consumption are unknown. Studies in animals suggest that release of endogenous opioids by ethanol promotes further consumption. To examine this issue in humans and to determine where in the brain endogenous opioids act to promote alcohol consumption, we measured displacement of a radiolabeled μ opioid receptor agonist, [¹¹C]carfentanil, before and immediately after alcohol consumption in both heavy drinkers and control subjects. Drinking alcohol induced opioid release in the nucleus accumbens and orbitofrontal cortex, areas of the brain implicated in reward valuation. Opioid release in the orbitofrontal cortex and nucleus accumbens was significantly positively correlated. Furthermore, changes in orbitofrontal cortex binding correlated significantly with problem alcohol use and subjective high in heavy drinkers, suggesting that differences in endogenous opioid function in these regions contribute to excessive alcohol consumption. These results also suggest a possible mechanism by which opioid antagonists such as naltrexone act to treat alcohol abuse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238334     DOI: 10.1126/scitranslmed.3002902

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  87 in total

1.  Two-hit exposure to polychlorinated biphenyls at gestational and juvenile life stages: 2. Sex-specific neuromolecular effects in the brain.

Authors:  Margaret R Bell; Bethany G Hart; Andrea C Gore
Journal:  Mol Cell Endocrinol       Date:  2015-11-24       Impact factor: 4.102

Review 2.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

3.  Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.

Authors:  Janice C Froehlich; Brett J Hausauer; Dennis D Rasmussen
Journal:  Alcohol Clin Exp Res       Date:  2013-07-22       Impact factor: 3.455

4.  Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool.

Authors:  Erica N Grodin; Spencer Bujarski; Alexandra Venegas; Wave-Ananda Baskerville; Steven J Nieto; J David Jentsch; Lara A Ray
Journal:  Alcohol Alcohol       Date:  2019-12-01       Impact factor: 2.826

Review 5.  Time to connect: bringing social context into addiction neuroscience.

Authors:  Markus Heilig; David H Epstein; Michael A Nader; Yavin Shaham
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

6.  Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.

Authors:  Jennifer M Mitchell; James P O'Neil; William J Jagust; Howard L Fields
Journal:  Clin Transl Sci       Date:  2013-06-13       Impact factor: 4.689

Review 7.  Interrelations between pain and alcohol: An integrative review.

Authors:  Emily L Zale; Stephen A Maisto; Joseph W Ditre
Journal:  Clin Psychol Rev       Date:  2015-02-25

8.  Gut microbiota modulates alcohol withdrawal-induced anxiety in mice.

Authors:  Hui-Wen Xiao; Chang Ge; Guo-Xing Feng; Yuan Li; Dan Luo; Jia-Li Dong; Hang Li; Haichao Wang; Ming Cui; Sai-Jun Fan
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

9.  Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.

Authors:  Jussi Lehto; Jarkko Johansson; Lauri Vuorilehto; Pauliina Luoto; Eveliina Arponen; Harry Scheinin; Juha Rouru; Mika Scheinin
Journal:  Psychopharmacology (Berl)       Date:  2015-04-29       Impact factor: 4.530

10.  Morphine withdrawal enhances constitutive μ-opioid receptor activity in the ventral tegmental area.

Authors:  Frank J Meye; Ruud van Zessen; Marten P Smidt; Roger A H Adan; Geert M J Ramakers
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.